Mangalam Drugs and Organics Ltd (MANGALAM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "51.92",
    "chg": 2.47,
    "chgp": "4.99%",
    "dir": 1,
    "prev_price": "49.45",
    "mcapval": "82.18 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE584F01014",
    "curr_date": "Jan 20",
    "curr_time": "",
    "bse_nse_vol": "47.87 k",
    "exc_status": "Active",
    "traded_date": "Jan 20, 2026",
    "traded_date_str": "2026 01 20",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-robust-buying-pressure-3794235",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_upper_circuit_3794235.png",
        "date": "2026-01-19 10:00:09",
        "description": "Mangalam Drugs and Organics Ltd surged to its upper circuit price limit on 19 Jan 2026, reflecting intense buying interest and a remarkable 5.0% gain in a single trading session. The stock’s performance outpaced its sector and benchmark indices, signalling renewed investor confidence despite a cautious backdrop."
      },
      {
        "title": "Are Mangalam Drugs and Organics Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-mangalam-drugs-and-organics-ltd-latest-results-good-or-bad-3793026",
        "imagepath": "",
        "date": "2026-01-16 19:11:48",
        "description": "Mangalam Drugs and Organics Ltd has reported significant challenges in its latest financial results for Q2 FY26. The company recorded a net loss of ₹7.35 crores, marking a substantial decline compared to the same quarter last year, where it had a profit. This loss reflects a complete erosion of profitability, with net sales dropping to ₹49.54 crores, the lowest quarterly figure in recent history, and representing a year-on-year contraction of 38.03%. \n\nThe operating margin turned negative at -5.77%, a stark contrast to the positive margin of 10.91% achieved in the previous year. This indicates severe operational distress, as the company has faced consecutive quarterly losses, with operating profits before depreciation, interest, and tax also reflecting significant losses. The interest burden has escalated to ₹5.03 crores, the highest on record, further complicating the company's financial position.\n\nOn a ha..."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3791611",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_upper_circuit_3791611.png",
        "date": "2026-01-14 10:00:06",
        "description": "Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 14 Jan 2026, closing at ₹44.77, marking a 5.0% gain on the day. This marks the 13th consecutive day of gains for the pharmaceutical micro-cap, reflecting robust investor interest despite a backdrop of subdued sector performance and falling delivery volumes."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-momentum-3789545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_upper_circuit_3789545.png",
        "date": "2026-01-12 10:00:09",
        "description": "Mangalam Drugs and Organics Ltd surged to its upper circuit price limit on 12 Jan 2026, reflecting robust buying interest and a remarkable 4.99% gain in a single trading session. The stock’s performance outpaced its sector and benchmark indices, signalling heightened investor enthusiasm despite a prevailing strong sell rating from MarketsMOJO."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3786835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_upper_circuit_3786835.png",
        "date": "2026-01-09 10:00:09",
        "description": "Mangalam Drugs and Organics Ltd surged to hit its upper circuit limit on 9 Jan 2026, propelled by robust buying interest and a significant price gain of 4.99% in a single trading session. The pharmaceutical micro-cap stock demonstrated exceptional momentum, outperforming its sector and broader market indices despite subdued investor participation."
      },
      {
        "title": "When is the next results date for Mangalam Drugs and Organics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-mangalam-drugs-and-organics-ltd-3785897",
        "imagepath": "",
        "date": "2026-01-08 23:16:19",
        "description": "The next results date for Mangalam Drugs and Organics Ltd is scheduled for 15 January 2026...."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-robust-buying-pressure-3785293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_upper_circuit_3785293.png",
        "date": "2026-01-08 10:00:10",
        "description": "Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 8 Jan 2026, propelled by robust buying interest and sustained investor enthusiasm. The stock closed at ₹36.84, marking a maximum daily gain of 4.99%, significantly outperforming its sector and the broader market indices."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-robust-buying-pressure-3784203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_upper_circuit_3784203.png",
        "date": "2026-01-07 10:00:05",
        "description": "Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 7 January 2026, propelled by strong investor demand and sustained buying momentum. The pharmaceutical micro-cap stock recorded a maximum daily gain of 5.0%, closing at ₹35.09, reflecting heightened market interest despite a broader Sensex decline."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3782887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_upper_circuit_3782887.png",
        "date": "2026-01-06 10:00:11",
        "description": "Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 6 Jan 2026, closing at ₹33.42 with a maximum daily gain of 5.0%. The stock demonstrated robust buying interest, outperforming its sector and broader market indices despite a decline in investor participation, signalling a complex but bullish trading session for this micro-cap pharmaceutical player."
      }
    ],
    "total": 153,
    "sid": "138636",
    "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "17-Jan-2026",
      "details": "Pursuant to Regulation 30 Schedule III Part A Para A(7B) Intimation of resignation of Shri Rukmesh P. Dhandhania- Independent Director of the Company w.e.f. 16th January 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "17-Jan-2026",
      "details": "Disclosure Pursuant to Regulation 30 Schedule III Part A Para 7(B) of SEBI(LODR) Regulations 2015 for resignation of Mr. Rukmesh P. Dhandhania -Independent Director of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Jan-2026",
      "details": "Intimation of Newspaper publication for declaration of Un-Audited Financial Results for the quarter ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Robust Buying Pressure

2026-01-19 10:00:09

Mangalam Drugs and Organics Ltd surged to its upper circuit price limit on 19 Jan 2026, reflecting intense buying interest and a remarkable 5.0% gain in a single trading session. The stock’s performance outpaced its sector and benchmark indices, signalling renewed investor confidence despite a cautious backdrop.

Read full news article

Are Mangalam Drugs and Organics Ltd latest results good or bad?

2026-01-16 19:11:48

Mangalam Drugs and Organics Ltd has reported significant challenges in its latest financial results for Q2 FY26. The company recorded a net loss of ₹7.35 crores, marking a substantial decline compared to the same quarter last year, where it had a profit. This loss reflects a complete erosion of profitability, with net sales dropping to ₹49.54 crores, the lowest quarterly figure in recent history, and representing a year-on-year contraction of 38.03%. The operating margin turned negative at -5.77%, a stark contrast to the positive margin of 10.91% achieved in the previous year. This indicates severe operational distress, as the company has faced consecutive quarterly losses, with operating profits before depreciation, interest, and tax also reflecting significant losses. The interest burden has escalated to ₹5.03 crores, the highest on record, further complicating the company's financial position. On a ha...

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-01-14 10:00:06

Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 14 Jan 2026, closing at ₹44.77, marking a 5.0% gain on the day. This marks the 13th consecutive day of gains for the pharmaceutical micro-cap, reflecting robust investor interest despite a backdrop of subdued sector performance and falling delivery volumes.

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Momentum

2026-01-12 10:00:09

Mangalam Drugs and Organics Ltd surged to its upper circuit price limit on 12 Jan 2026, reflecting robust buying interest and a remarkable 4.99% gain in a single trading session. The stock’s performance outpaced its sector and benchmark indices, signalling heightened investor enthusiasm despite a prevailing strong sell rating from MarketsMOJO.

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-01-09 10:00:09

Mangalam Drugs and Organics Ltd surged to hit its upper circuit limit on 9 Jan 2026, propelled by robust buying interest and a significant price gain of 4.99% in a single trading session. The pharmaceutical micro-cap stock demonstrated exceptional momentum, outperforming its sector and broader market indices despite subdued investor participation.

Read full news article

When is the next results date for Mangalam Drugs and Organics Ltd?

2026-01-08 23:16:19

The next results date for Mangalam Drugs and Organics Ltd is scheduled for 15 January 2026....

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Robust Buying Pressure

2026-01-08 10:00:10

Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 8 Jan 2026, propelled by robust buying interest and sustained investor enthusiasm. The stock closed at ₹36.84, marking a maximum daily gain of 4.99%, significantly outperforming its sector and the broader market indices.

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Robust Buying Pressure

2026-01-07 10:00:05

Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 7 January 2026, propelled by strong investor demand and sustained buying momentum. The pharmaceutical micro-cap stock recorded a maximum daily gain of 5.0%, closing at ₹35.09, reflecting heightened market interest despite a broader Sensex decline.

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-01-06 10:00:11

Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 6 Jan 2026, closing at ₹33.42 with a maximum daily gain of 5.0%. The stock demonstrated robust buying interest, outperforming its sector and broader market indices despite a decline in investor participation, signalling a complex but bullish trading session for this micro-cap pharmaceutical player.

Read full news article

View All News